Pharmacutical Small Molecule Prefilled Syringes Market | 页面 3

REPORT DESCRIPTION
Small Molecule Prefilled Syringes Market – Dynamics
Major drugs in the neurology drugs segment such as Copaxone (manufactured by Teva Pharmaceutical
Industries Ltd.) are expected to face competition from generics. Manufacturers such as Schott AG are
involved in prefilled syringe product innovation, in order to improve medical outcomes, which
compliments growth of the small molecule prefilled syringe market. The market is expected to exhibit
significant growth, owing to increasing adoption of technologically advanced prefilled syringes such as
Schott TopPac. Advantages offered by prefilled syringes such as accurate dosage, and instant therapeutic
effect over conventional products such as tablets and capsules is expected to foster growth of small
molecule prefilled syringes market.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1629